Drugs / PEG sTNF-R1
last change Jun 2003 re-read 2 minutes ago

PEG sTNF-R1

Developed for
rheumatoid arthritis
Investigated by
Amgen

Trials 1 · a red edge is where a trial was stopped

200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00537667 Aug 2001 → Mar 2003 rheumatoid arthritis Amgen Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as PEG sTNF-R1 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00537667